Abstract P2-01-16: Pharmacogenomic variants and risk of adverse events in breast cancer patients treated with Trastuzumab-deruxtecan: results from the PROCURE projectRodrigo Sánchez-Bayona, Cristina Rodríguez‐Antona, Cristina Saura et al.|Clinical Cancer Research|2025Cited by 3